In this study, the PPK model of VRC in CAPA patients was established for the first time, and the in vivo process of VRC could be described by one-compartment model with first-order elimination, and five covariates that significantly affect VRC metabolism, such as CRRT, CRP, GGT, PLT, and AST. This evidence concerns the gene NAAA and episodic ataxia type 2.